argus

Shukra Pharmaceuticals Limited

NSE: SHUKRAPHARINE551C01044₹2,286 Cr

Timeline

Time (IST)TypeMEventSrc
29 Nov, 06:43 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November 29.2025.bse
13 Nov, 06:16 pm—…Shukra Pharmaceuticals Ltd - 524632 - Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2025, Along With The Auditors' Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.bse
13 Nov, 06:14 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of Board Meeting Held On November 13, 2025.bse
10 Nov, 03:04 pm—…Shukra Pharmaceuticals Ltd - 524632 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Incorporation Of Subsidiary Company.bse
31 Oct, 07:00 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September, 2025 Along With The Auditor''s Limited Review Report.bse
31 Oct, 06:52 pm—…Shukra Pharmaceuticals Ltd - 524632 - Receipt Of Distributorship Rightsbse
24 Oct, 07:35 pm—…Shukra Pharmaceuticals Ltd - 524632 - Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary Companybse
08 Oct, 02:22 pm—…Shukra Pharmaceuticals Ltd - 524632 - Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYSTEM FOR ORTHOPEDICS At Directorate General Armed Forces Medical Services And INHS Asvini, Maharashtra.bse
04 Oct, 12:56 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday, October 03, 2025.bse
03 Oct, 06:53 pm—…Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Issue of Securitiesbse
03 Oct, 06:51 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Friday, October 03, 2025.bse
22 Sept, 04:29 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Preferential Issue Of Warrants As Per Chapter V And In Accordance With Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations 2018 To Promoters Subject To Approval Of Shareholders.bse
12 Sept, 05:51 pm—…Shukra Pharmaceuticals Ltd - 524632 - Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual General Meeting Of The Company.bse
12 Sept, 05:48 pm—…Shukra Pharmaceuticals Ltd - 524632 - Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.bse
12 Sept, 05:38 pm—…Shukra Pharmaceuticals Ltd - 524632 - Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The Companybse
10 Sept, 10:47 am—…Shukra Pharmaceuticals Ltd - 524632 - Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-Upbse
08 Sept, 07:31 pm—…Shukra Pharmaceuticals Ltd - 524632 - Reg. 34 (1) Annual Report.bse
08 Sept, 02:27 pm—…Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Board Of Directors Of The Company.bse